Booster shot for chickenpox: study seeks stronger protection for kids
NCT ID NCT07475000
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well a second dose of the chickenpox vaccine works and if it is safe for healthy children aged 15 months to 12 years. About 300 children who already had one dose at 12 months old will get a second dose made by Sinovac. Researchers will measure antibody levels before and 42 days after the shot and track any side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VARICELLA (CHICKENPOX) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Akdeniz University Health, Research and Application Center (Hospital), Department of Child Health and Diseases, Department of Social Pediatrics
RECRUITINGAkdeniz, Turkey (Türkiye)
Contact Email: •••••@•••••
-
Ankara Bilkent City Hospital, Pediatrics and Pediatric Infectious Diseases Clinic
NOT_YET_RECRUITINGAnkara, Turkey (Türkiye)
Contact Email: •••••@•••••
-
Ege University Hospital (Application and Research Center) Department of Child Health and Diseases
NOT_YET_RECRUITINGEge, Turkey (Türkiye)
Contact Email: •••••@•••••
-
Hacettepe University Hospitals, Department of Pediatrics, Department of Social Pediatrics
RECRUITINGAnkara, Turkey (Türkiye)
Contact Email: •••••@•••••
-
REPUBLIC of TURKEY MINISTRY of HEALTH ANKARA BILKENT CITY HOSPITAL
NOT_YET_RECRUITINGAnkara, Turkey (Türkiye)
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.